NEW YORK (GenomeWeb News) – Horizon Discovery said today that the National Institutes of Health Center for Regenerative Medicine will use its genome editing technology in disease studies to discover how specific genes affect stem cells.

Under the technology access agreement, NIH CRM will use Horizon's Genesis technology to engineer stem cells to create isogenic disease models with specific induced mutations and lineage markers to understand the effects certain genes have on stem cells as they differentiate.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.